GlycoMimetics, Inc.
Highly potent multimeric e-selectin antagonists

Last updated:

Abstract:

Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin to an E-selectin ligand are disclosed. For example, highly potent multimeric E-selectin antagonist are desorbed and pharmaceutical compositions comprising at least one of the same.

Status:
Grant
Type:

Utility

Filling date:

6 Oct 2017

Issue date:

27 Jul 2021